We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-4.41%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$6.21B
AUM Growth
-$804M
Cap. Flow
-$184M
Cap. Flow %
-2.96%
Top 10 Hldgs %
40.63%
Holding
166
New
10
Increased
38
Reduced
80
Closed
12

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$32.4M
2
UNH icon
UnitedHealth
UNH
+$23.7M
3
CI icon
Cigna
CI
+$21.4M
4
HUM icon
Humana
HUM
+$20.1M
5
APLS
Apellis Pharmaceuticals
APLS
+$12.1M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$72.3M
2
MDT icon
Medtronic
MDT
+$64.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$33M
4
CRL icon
Charles River Laboratories
CRL
+$17.5M
5
TMO icon
Thermo Fisher Scientific
TMO
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.13%
2 Industrials 0.77%
3 Energy 0.04%
4 Communication Services 0.01%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
101
DELISTED
Seagen Inc. Common Stock
SGEN
$4.67M 0.08%
22,000
– –
BIIB icon
102
Biogen
BIIB
$30B
$4.45M 0.07%
17,314
-8,284
-32% -$2.22M
ESPR
103
DELISTED
Esperion Therapeutics
ESPR
$4.12M 0.07%
4,204,264
-4,000
-0.1% -$5.79K
NVRO
104
DELISTED
NEVRO CORP.
NVRO
$3.81M 0.06%
198,171
-20,402
-9% -$435K
JNJ icon
105
Johnson & Johnson
JNJ
$605B
$3.55M 0.06%
22,823
+1,598
+8% +$264K
OLK
106
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$3.2M 0.05%
217,256
-22,368
-9% -$375K
COR icon
107
Cencora
COR
$59.3B
$3.08M 0.05%
17,087
+1,177
+7% +$217K
CVS icon
108
CVS Health
CVS
$138B
$2.47M 0.04%
35,314
– –
MCK icon
109
McKesson
MCK
$97.4B
$2.36M 0.04%
5,425
+2,129
+65% +$897K
KOS icon
110
Kosmos Energy
KOS
$1.36B
$2.32M 0.04%
284,000
-34,300
-11% -$243K
ALKS icon
111
Alkermes
ALKS
$8.75B
$2.29M 0.04%
81,700
– –
GH icon
112
Guardant Health
GH
$19.7B
$2.21M 0.04%
74,525
-7,672
-9% -$270K
BBIO icon
113
BridgeBio Pharma
BBIO
$15.9B
$2.08M 0.03%
78,700
-18,200
-19% -$516K
VTRS icon
114
Viatris
VTRS
$20B
$1.74M 0.03%
+176,848
New +$1.84M
RYTM icon
115
Rhythm Pharmaceuticals
RYTM
$7.21B
$1.68M 0.03%
+73,300
New +$1.64M
PCVX icon
116
Vaxcyte
PCVX
$8.01B
$1.55M 0.03%
30,500
+4,500
+17% +$222K
KRYS icon
117
Krystal Biotech
KRYS
$10.3B
$1.45M 0.02%
12,500
-5,500
-31% -$671K
LH icon
118
Labcorp
LH
$23.1B
$1.4M 0.02%
6,988
-1,146
-14% -$242K
CERT icon
119
Certara
CERT
$1.07B
$1.33M 0.02%
+91,606
New +$1.54M
RXRX icon
120
Recursion Pharmaceuticals
RXRX
$1.52B
$1.33M 0.02%
+174,085
New +$1.74M
AKRO
121
DELISTED
Akero Therapeutics
AKRO
$1.26M 0.02%
25,000
-2,100
-8% -$97.8K
DVAX
122
DELISTED
Dynavax Technologies
DVAX
$1.23M 0.02%
+83,200
New +$1.17M
KRTX
123
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.17M 0.02%
6,900
-3,200
-32% -$602K
ZTS icon
124
Zoetis
ZTS
$31.7B
$1.12M 0.02%
6,462
-34
-0.5% -$6.17K
SPY icon
125
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$1.11M 0.02%
2,600
+800
+44% +$356K
3 4
5
6 7

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q3 2023 Portfolio in Review

As of Q3 2023, Bellevue Group held 166 positions worth $6.21B, down 11% from $7.01B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bellevue Group's Q3 2023 filing shows 10 new, 38 increased, 80 reduced and 12 closed positions. Its largest new stake was Viatris: 176,848 shares worth $1.74M. The largest sale was Inspire Medical Systems, an estimated $72.3M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Industrials and Energy.

  • Bellevue Group's largest Q3 2023 buy was Viatris: 176,848 shares worth $1.74M.
  • Bellevue Group added most to Elevance Health in Q3 2023, an estimated $32.4M increase.
  • Bellevue Group's biggest Q3 2023 reduction was Inspire Medical Systems, cutting an estimated $72.3M.
  • Bellevue Group fully exited Baxter International in Q3 2023, selling an estimated $9.72M.
  • Bellevue Group's ten largest holdings make up 41% of its $6.21B portfolio in Q3 2023.
  • Bellevue Group opened 10 new positions and closed 12 in Q3 2023.
  • Bellevue Group's portfolio value fell 11% quarter-over-quarter to $6.21B.

Based on Bellevue Group's 13F filing for Q3 2023, filed 14 Nov 2023.